Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

Allegiant’s business is heavily dependent on leisure travel, which experts fear may see a drop as consumers cut back. Sun ...

The various trials covered time periods ranging from 40 to 52 weeks and included three different strengths of Mounjaro: 5 mg, 10 mg ... weight-loss product as Wegovy. It’s still Ozempic ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Finding the best weight loss supplements for women (or anyone, really) can be like finding a needle in a haystack — except ...